Page last updated: 2024-11-13

1,2,4-trioxane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,2,4-trioxane: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID21584057
MeSH IDM0488845

Synonyms (8)

Synonym
7049-17-4
1,2,4-trioxane
DTXSID30616113
Q2806555
x5cwb98j7s ,
pm 443
as-trioxane
unii-x5cwb98j7s

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" multilocularis metacestodes was performed at 20μM, and selected ozonides were further assessed in dose-response studies in metacestode cultures and mammalian cells."( Amino ozonides exhibit in vitro activity against Echinococcus multilocularis metacestodes.
Dong, Y; Hemphill, A; Keiser, J; Kriegel, N; Küster, T; Stadelmann, B; Vennerstrom, JL; Wang, X, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (102)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (6.86)18.7374
1990's0 (0.00)18.2507
2000's30 (29.41)29.6817
2010's52 (50.98)24.3611
2020's13 (12.75)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.69

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.69 (24.57)
Research Supply Index4.66 (2.92)
Research Growth Index4.50 (4.65)
Search Engine Demand Index23.70 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.69)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews11 (10.48%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other94 (89.52%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]